K972121

Substantially Equivalent

ACUITY CENTRAL STATION

Applicant: Protocol Systems, Inc.
Product code: MLD
Advisory panel: Cardiovascular
Date received: 1997-06-05
Decision date: 1997-11-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Beaverton, OR, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.